Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease

被引:29
|
作者
Bannai, Ei [1 ]
Yamashita, Hiroyuki [1 ]
Kaneko, Shunta [1 ]
Ueda, Yo [1 ]
Ozaki, Takashi [1 ]
Tsuchiya, Haruka [1 ]
Takahashi, Yuko [1 ]
Kaneko, Hiroshi [1 ]
Kano, Toshikazu [1 ]
Mimori, Akio [1 ]
机构
[1] Natl Ctr Global Hlth & Med, Div Rheumat Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan
关键词
Adult-onset Still's disease; Tocilizumab; Macrophage activation syndrome; MACROPHAGE ACTIVATION SYNDROME; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; RECEPTOR ANTIBODY; IL-6; RECEPTOR; EFFICACY; INTERLEUKIN-6; AGENTS; TRIAL;
D O I
10.3109/14397595.2014.899178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the effects of tocilizumab (TCZ) on adult-onset Still's disease (AOSD), we reviewed medical records of seven patients with refractory AOSD treated with TCZ at our institution. TCZ therapy might allow rapid corticosteroid tapering and help maintain remission status, that is, resolution of clinical symptoms and normalization of biomarkers such as CRP and ferritin. Patients, however, should be monitored for the development of macrophage activation syndrome when TCZ is administered for active AOSD.
引用
收藏
页码:297 / 301
页数:5
相关论文
共 50 条
  • [21] Treatment of refractory adult-onset still’s disease with tocilizumab: report of two cases and review of the literature
    Rene Thonhofer
    Manuela Hiller
    Horst Just
    Markus Trummer
    Cornelia Siegel
    Christian Dejaco
    Rheumatology International, 2011, 31 : 1653 - 1656
  • [22] Biologics for the treatment of adult-onset still's disease
    Yoo, Dae Hyun
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (11) : 1173 - 1190
  • [23] Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review
    Park, Eun Hye
    Lee, Eun Young
    Shin, Kichul
    Kim, Hyoun-Ah
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (05) : 791 - 798
  • [24] Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab
    Matsumoto, Kazuko
    Nagashima, Takao
    Takatori, Shino
    Kawahara, Yuta
    Yagi, Masaki
    Iwamoto, Masahiro
    Okazaki, Hitoaki
    Minota, Seiji
    CLINICAL RHEUMATOLOGY, 2009, 28 (04) : 485 - 487
  • [25] A case of corticosteroid-refractory adult-onset Still's disease successfully controlled with tocilizumab despite transient neutropenia and thrombocytopenia
    Iwata, Jun-ichi
    Yamamura, Hitomi
    Takano, Aiko
    Horiuchi, Yoshihito
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (03) : 62 - 66
  • [26] Successful treatment of adult-onset Still’s disease with tocilizumab monotherapy: two case reports and literature review
    Ryota Sakai
    Hayato Nagasawa
    Eiko Nishi
    Ayumi Okuyama
    Hirofumi Takei
    Takahiko Kurasawa
    Tsuneo Kondo
    Koji Nishimura
    Yuichiro Shirai
    Tatsuya Ito
    Hideto Kameda
    Tsutomu Takeuchi
    Koichi Amano
    Clinical Rheumatology, 2012, 31 : 569 - 574
  • [27] Current and emerging biological therapy in adult-onset Still's disease
    Ma, Yuning
    Meng, Jianfen
    Jia, Jinchao
    Wang, Mengyan
    Teng, Jialin
    Zhu, Dehao
    Yang, Chengde
    Hu, Qiongyi
    RHEUMATOLOGY, 2021, 60 (09) : 3986 - 4000
  • [28] Successful re-administration of tocilizumab in a patient with adult-onset Still's disease after improvement of macrophage activation syndrome
    Nagasawa, Yuma
    Takase-Minegishi, Kaoru
    Adachi, Soichiro
    Ichikawa, Kento
    Nagai, Hideto
    Watanabe, Tomoya
    Yamaguchi, Yukie
    Yoshimi, Ryusuke
    Kirino, Yohei
    Nakajima, Hideaki
    MODERN RHEUMATOLOGY CASE REPORTS, 2025,
  • [29] Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still's Disease
    Li, Sheng
    Zheng, Siting
    Tang, Shunli
    Pan, Yunlei
    Zhang, Shan
    Fang, Hong
    Qiao, Jianjun
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2020, 58 (01) : 71 - 81
  • [30] Tocilizumab in Refractory Adult Still's Disease
    Puechal, Xavier
    de Bandt, Michel
    Berthelot, Jean-Marie
    Breban, Maxime
    Dubost, Jean-Jacques
    Fain, Olivier
    Kahn, Jean-Emmanuel
    Lequen, Laurence
    Longy-Boursier, Maite
    Perdriger, Aleth
    Schaeverbeke, Thierry
    Toussirot, Eric
    Sibilia, Jean
    ARTHRITIS CARE & RESEARCH, 2011, 63 (01) : 155 - 159